NIH-funded research NIH-funded research

Immune memory after COVID-19, vaccination, and other respiratory infections

Official title: Human immune memory to COVID-19, vaccines, and respiratory pathogens

Funded at La Jolla Institute for Immunology · NIH-11377291 · Data updated 2026-11-12

This project looks at how people's immune systems remember COVID-19, vaccines, and similar respiratory infections to help improve protection.

More COVID-19 research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionLa Jolla Institute for Immunology
NIH-funded
Lab location1 site (La Jolla, United States)
Project startMarch 11, 2019
Project endFebruary 28, 2029
Funding year2026
Award (this year)$2,573,442
NIH project number5U19AI142742-08
Project IDNIH-11377291 on NIH RePORTER

Who could benefit from this research

Could help

Ideal participants include people who have had COVID-19 or who have received COVID vaccines and are willing to provide blood samples and health information over time.

Less likely to help

People whose medical needs are unrelated to respiratory infections or who cannot give blood samples are unlikely to gain direct benefit from participating.

What this research studies

You would be asked to give blood and brief health information so researchers can measure antibodies and immune cells. Scientists at the La Jolla Institute will compare immune memory in people who've had COVID, people who received different vaccines, and people exposed to other respiratory germs. They will use lab tests that count B cells, CD4+ and CD8+ T cells, and antibody levels and will follow participants over months or years to see how protection changes. That information will be used to understand who keeps good protection and to guide booster timing and better vaccine designs.

Why it matters

Potential benefit: If successful, this work could help identify who needs boosters, improve vaccine schedules, and guide design of longer-lasting COVID and respiratory vaccines.

How similar studies have gone: Earlier La Jolla Institute and other studies have already shown clear T and B cell responses to COVID and vaccines, so this work builds on successful, well-established findings.

Where this research is happening

  • La Jolla Institute for Immunology
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Crotty, Shane P — La Jolla Institute for Immunology
  • Study coordinator: Crotty, Shane P

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.